DYAI DYADIC INTERNATIONAL INC

Nasdaq Biological Products, (No Diagnostic Substances) DE CIK: 0001213809
AI RATING
STRONG_SELL
92% Confidence

Investment Thesis

Dyadic International exhibits severe fundamental deterioration with negative stockholders' equity (-$407.7K), massive operating losses (-$1.9M) on minimal revenue ($1.1M), and accelerating cash burn (-$2.0M annually). The company's $4.2M cash position provides only ~2 years of runway at current burn rates, with no visible path to profitability and declining revenue trajectory.

Strengths

  • + Maintains $4.2M in cash providing near-term operational runway
  • + Current ratio of 2.42x indicates adequate short-term liquidity to meet obligations
  • + Early-stage biotech with potential for future development pipeline (though unproven)

Risks

  • ! Negative stockholders' equity of -$407.7K represents technical balance sheet insolvency
  • ! Operating losses of -$1.9M exceed revenue of $1.1M by 173% - fundamentally unsustainable
  • ! Cash burn rate of -$2.0M annually will exhaust liquidity within 18-24 months without improvement or capital raise
  • ! Revenue declining -11.6% YoY indicates worsening operational conditions
  • ! Zero insider Form 4 filings in last 90 days suggests lack of management confidence

Key Metrics to Watch

Financial Metrics

Revenue
1.1M
Net Income
-2.0M
EPS (Diluted)
$-0.05
Free Cash Flow
-2.0M
Total Assets
7.8M
Cash
4.2M

Profitability Ratios

Gross Margin N/A
Operating Margin -171.3%
Net Margin -175.9%
ROE N/A
ROA -25.0%
FCF Margin -176.7%

Balance Sheet & Liquidity

Current Ratio
2.42x
Quick Ratio
2.42x
Debt/Equity
N/A
Debt/Assets
105.2%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-15T09:09:36.516171 | Data as of: 2026-03-31 | Powered by Claude AI